A Drosophila model of prion disease and its metabolic changes in the brain
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.70048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Dongdong Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affair…. Hauptthemen laut MEDLINE: Disease Models, Animal, Prion Diseases, Brain, Drosophila melanogaster. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program, Hainan Province Science and Technology Special Fund, Beijing Municipal Natural Science Foundation.
Abstract (Originalsprache)
Background
Prion diseases (PrDs) are fatal transmissible neurodegenerative disorders caused by misfolded prion protein, which is highly expressed in the brain. Drosophila has been employed as a model system for studying mammalian neurodegenerative diseases.
Methods
Drosophila transgenic for hamster prion protein (HaPrP) was generated by Valium20 transformation. Locomotion, longevity, protease resistance, and histology were assessed, and nontargeted metabolomics analyses were performed to investigate the changes in Drosophila metabolism with the HaPrP expression and metformin treatment.
Results
The Drosophila model exhibited pan‐neuronal expression of HaPrP, with expression levels increasing with age. Flies displayed reduced climbing ability, shortened lifespan, and vacuolar structures in the brain. Additionally, HaPrP expressed in older flies demonstrated resistance to digestion by 5 μg/mL Proteinase K. The Drosophila model also displayed alterations in protein, lipid, and carbohydrate metabolism. We hypothesize that glutamate, N ‐acetylaspartate, ceramide, phosphatidylethanolamine, dihydroxyacetone phosphate, ribose‐5‐phosphate, and pyruvate are key metabolites potentially related to PrDs. Metformin improved locomotor activity, reduced PrP res formation, and ameliorated mitochondrial dysfunction in flies, which may be associated with alterations in succinate, pyruvate, choline, and sphingomyelin levels.
Conclusions
We generated a Drosophila model of PrDs that recapitulates key pathological features observed in mammals. Preliminary applications have demonstrated that the Drosophila model is suitable for PrDs research and the high‐throughput screening of potential therapeutic compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory of Animal Epidemiology of the Ministry of Agriculture and Rural Affairs, National Animal Transmissible Spongiform Encephalopathy Laboratory,…
ORCID-Profile: Lifeng Yang
Förderung
- National Key Research and Development Program
- Hainan Province Science and Technology Special Fund
- Beijing Municipal Natural Science Foundation
- Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Wang, D., Sun, Z., Wen, P., Zhao, M., He, Y., Gou, F., Wang, J., Fan, Q., Li, X., Ma, T., Wang, X., Li, W., Chen, S., Zhao, D., & Yang, L. (2025). A Drosophila model of prion disease and its metabolic changes in the brain. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70048
Vancouver
Wang D, Sun Z, Wen P, Zhao M, He Y, Gou F, et al. A Drosophila model of prion disease and its metabolic changes in the brain. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70048
BibTeX
@article{Wang2025,
author = {Wang, Dongdong and Sun, Zhixin and Wen, Pei and Zhao, Mengyang and He, Yuheng and Gou, Fengting and Wang, Jingjing and Fan, Qing and Li, Xueyuan and Ma, Tianying and Wang, Xiaoyu and Li, Wen and Chen, Sen and Zhao, Deming and Yang, Lifeng},
title = {A Drosophila model of prion disease and its metabolic changes in the brain},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.70048}
}
EUVIMED